Acura Pharmaceuticals VP, Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc Albert Brzeczko's 2020 pay jumps 22% to $220K
Acura Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: 2 minutes ago
Acura Pharmaceuticals reported fiscal year 2020 executive compensation information on April 12, 2021.
In 2020, three executives at Acura Pharmaceuticals received on average a compensation package of $190K, a 22% increase compared to previous year.
Average pay of disclosed executives at Acura Pharmaceuticals
Albert W. Brzeczko, VP, Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc, received $220K in total, which increased by 22% compared to 2019. 100% of Brzeczko's compensation, or $220K, was in salary.
Peter A. Clemens, Chief Financial Officer, received a compensation package of $200K, which increased by 22% compared to previous year. 100% of the compensation package, or $200K, was in salary.
Robert B. Jones, Chief Executive Officer, earned $150K in 2020, a 22% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2021.